Detalhe da pesquisa
1.
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.
Haematologica
; 107(12): 2823-2833, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35295076
2.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica
; 106(1): 39-45, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31879328
3.
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Blood Adv
; 6(8): 2510-2516, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34731884
4.
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
Cancers (Basel)
; 13(5)2021 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33802502
5.
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
Leuk Lymphoma
; 63(4): 996-1000, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34806525
6.
Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms.
Leuk Lymphoma
; 63(7): 1754-1757, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35253587
7.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Leukemia
; 36(6): 1685-1688, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35422094